Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Participant-Level Data and the New Frontier in Trial Transparency
by
Zarin, Deborah A
in
Access to Information
/ Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy
/ Antibodies, Monoclonal, Murine-Derived - administration & dosage
/ Azathioprine - therapeutic use
/ Clinical trials
/ Clinical Trials as Topic
/ Cyclophosphamide - therapeutic use
/ Drug Industry
/ Humans
/ Immunologic Factors - administration & dosage
/ Information Dissemination
/ Public access
/ Rituximab
2013
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Participant-Level Data and the New Frontier in Trial Transparency
by
Zarin, Deborah A
in
Access to Information
/ Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy
/ Antibodies, Monoclonal, Murine-Derived - administration & dosage
/ Azathioprine - therapeutic use
/ Clinical trials
/ Clinical Trials as Topic
/ Cyclophosphamide - therapeutic use
/ Drug Industry
/ Humans
/ Immunologic Factors - administration & dosage
/ Information Dissemination
/ Public access
/ Rituximab
2013
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Participant-Level Data and the New Frontier in Trial Transparency
by
Zarin, Deborah A
in
Access to Information
/ Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy
/ Antibodies, Monoclonal, Murine-Derived - administration & dosage
/ Azathioprine - therapeutic use
/ Clinical trials
/ Clinical Trials as Topic
/ Cyclophosphamide - therapeutic use
/ Drug Industry
/ Humans
/ Immunologic Factors - administration & dosage
/ Information Dissemination
/ Public access
/ Rituximab
2013
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Participant-Level Data and the New Frontier in Trial Transparency
Journal Article
Participant-Level Data and the New Frontier in Trial Transparency
2013
Request Book From Autostore
and Choose the Collection Method
Overview
Medical progress is possible only because altruistic volunteers put themselves at risk in clinical trials. The results of those trials are then used to inform medical decisions. The traditional system of relying on investigators, sponsors, and journal editors to decide whether, when, and how to report trial results was based on trust. There was no way to know what trials had been conducted, what data were collected, how they were analyzed, and whether the reported data were complete and accurate. Policies mandating the registration of trials and the reporting of summary results were instituted to provide greater transparency. In turn, . . .
Publisher
Massachusetts Medical Society
This website uses cookies to ensure you get the best experience on our website.